ArticleEuropean journal of ageing2018
What is the duration of life expectancy in the state of frailty? Estimates in the SIPAF study.
Article in European journal of ageing, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Frailty in older adults admitted to hospital: a six-year dual-centre retrospective study of over 53 000 clinical frailty scale assessments.Age and ageing · 2025Observational
- Frailty-free life expectancy and its association with socio-economic characteristics: an analysis of the English Longitudinal Study of Ageing cohort study.BMC medicine · 2025Article
- Managing right-sided colon cancer in the frail patient.Surgical endoscopy · 2025Article
- Living Longer But Frailer? Temporal Trends in Life Expectancy and Frailty in Older Swedish Adults.The journals of gerontology. Series A, Biological sciences and medical sciences · 2024Article
- Geriatric frailty determinants in India.Aging medicine (Milton (N.S.W)) · 2023Article
- Comparison of Claims-Based Frailty Indices in U.S. Veterans 65 and Older for Prediction of Long-Term Institutionalization and Mortality.The journals of gerontology. Series A, Biological sciences and medical sciences · 2023Article
- Life expectancy among older adults with or without frailty in China: multistate modelling of a national longitudinal cohort study.BMC medicine · 2023Article
- Age is just a number: the concept of time to benefit in older adults.European journal of hospital pharmacy : science and practice · 2023Article
- Life Expectancy in Pre-Frail and Frail States with and without Disability: 18-Years of Follow-Up Data from the HEPESE Study Using the Markov Chain Method.The Journal of frailty & aging · 2023Article
- Trends over two decades in life expectancy with complex health problems among older Swedes: implications for the provision of integrated health care and social care.BMC public health · 2022Article
- New thinking about health expectancy: introduction to the special section.European journal of ageing · 2021Article
- Education, wealth, and duration of life expected in various degrees of frailty.European journal of ageing · 2021Article
- Healthy life expectancy by frailty state in Europe from 2004 to 2015: findings from SHARE.European journal of public health · 2021Article
- Inequalities in Life Expectancy With Frailty Among Brazilian Older Adults: A Multistate Approach.Innovation in aging · 2019Article
- A cross-sectional study examining convergent validity of a frailty index based on electronic medical records in a Canadian primary care program.BMC geriatrics · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The screening of frailty can trigger interventions aiming to delay disability in older people. Whereas the prevalence, the consequences, and the factors associated with frailty are well described, little is known about the duration of the state of frailty. This study aimed to estimate the time spent in the state of frailty in men and women using the Sullivan method. Data used were the age- and sex-specific prevalence of frailty found in SIPAF study ("Système d'Information sur la Perte d'Autonomie Fonctionnelle de la personne âgée") and statistics of mortality from the Human Mortality Database. The SIPAF study included 2350 individuals aged 70 and over and living in France. Participants were interviewed at home by trained nurses. Frailty was defined as impairment in three domains or more among nutrition, energy, physical activity, strength, and mobility. People requiring assistance in basic activities of daily living were considered in a separate category. Mean age of the study sample was 83.3 ± 7.5 years, with 59.4% of women. Overall, the prevalence of pre-frailty, frailty, and dependency was 39.1, 17.0, and 15.4%, respectively. Life expectancy at age 70 was 18.3 years for women, of which 7.4 years (95% CI 6.9-7.9) were pre-frail, 3.4 years (95% CI 3.0-3.8) frail, and 2.4 (95% CI 2.1-2.7) with disability. In contrast, LE for men at 70 was 14.8 years, of which pre-frail, frail, and disabled years were 6.0 years (95% CI 5.5-6.5), 1.2 years (95% CI 1.0-1.5), and 1.2 (95% CI 1.0-1.5), respectively. In conclusion, frailty is a transition state that is relatively limited in time compared to pre-frailty that may represent a larger time window for prevention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.